123 related articles for article (PubMed ID: 19875354)
1. Effect of the class I metabotropic glutamate receptor antagonist AIDA on certain behaviours in rats with experimental chronic hyperammonemia.
Grzeda E; Wiśniewska RJ
Adv Med Sci; 2009; 54(2):269-76. PubMed ID: 19875354
[TBL] [Abstract][Full Text] [Related]
2. AIDA influences behavior in rats pretreated with baclofen.
Car H; Nadlewska A; Oksztel R; Wiśniewski K
Pol J Pharmacol; 2001; 53(3):245-52. PubMed ID: 11785925
[TBL] [Abstract][Full Text] [Related]
3. The anxiolytic-like activity of AIDA (1-aminoindan-1,5-dicarboxylic acid), an mGLu 1 receptor antagonist.
Kłodzińska A; Tatarczyńska E; Stachowicz K; Chojnacka-Wójcik E
J Physiol Pharmacol; 2004 Mar; 55(1 Pt 1):113-26. PubMed ID: 15082872
[TBL] [Abstract][Full Text] [Related]
4. The influence of NMDA, a potent agonist of glutamate receptor, on behavioral activity of rats with experimental hyperammonemia evoked by liver failure.
Fedosiewicz-Wasiluk M; Hoły ZZ; Wiśniewska RJ; Wiśniewski K
Amino Acids; 2005 Feb; 28(1):111-7. PubMed ID: 15700110
[TBL] [Abstract][Full Text] [Related]
5. Influence of AIDA on certain behaviors in rats subjected to experimental hypoxia.
Nadlewska A; Car H; Wiśniewska RJ; Wiśniewski K
Pol J Pharmacol; 2003; 55(2):171-80. PubMed ID: 12926544
[TBL] [Abstract][Full Text] [Related]
6. Modulation of defensive responses and anxiety-like behaviors by group I metabotropic glutamate receptors located in the dorsolateral periaqueductal gray.
Lima VC; Molchanov ML; Aguiar DC; Campos AC; Guimarães FS
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):178-85. PubMed ID: 17804134
[TBL] [Abstract][Full Text] [Related]
7. Group I metabotropic glutamate antagonist reduces acute neuronal degeneration and behavioral deficits after traumatic brain injury in rats.
Lyeth BG; Gong QZ; Shields S; Muizelaar JP; Berman RF
Exp Neurol; 2001 May; 169(1):191-9. PubMed ID: 11312571
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of 1-aminoindan-1,5-dicarboxylic acid, a potent mGluR1 antagonist.
Moroni F; Lombardi G; Thomsen C; Leonardi P; Attucci S; Peruginelli F; Torregrossa SA; Pellegrini-Giampietro DE; Luneia R; Pellicciari R
J Pharmacol Exp Ther; 1997 May; 281(2):721-9. PubMed ID: 9152378
[TBL] [Abstract][Full Text] [Related]
9. 2R,4R-APDC influence on hypoxia-induced impairment of learning and memory processes in passive avoidance test.
Car H; Wiśniewska RJ; Wiśniewski K
Pol J Pharmacol; 2004; 56(5):527-37. PubMed ID: 15591640
[TBL] [Abstract][Full Text] [Related]
10. Influence of NMDA, a potent agonist of glutamate receptors, on behavioral activity in 4-week streptozotocin-induced diabetic rats.
Wiśniewski K; Fedosiewicz-Wasiluk M; Hoły ZZ; Car H; Grzeda E
Pol J Pharmacol; 2003; 55(3):345-51. PubMed ID: 14506313
[TBL] [Abstract][Full Text] [Related]
11. Effect of MPEP on rat's behavioral activity in experimental episodes of hypoxia.
Nadlewska A; Wiśniewska RJ
Adv Med Sci; 2009; 54(2):277-82. PubMed ID: 20022861
[TBL] [Abstract][Full Text] [Related]
12. Behavioral effects of the selective blockade of metabotropic glutamate receptor subtype 5 in experimental hypoxia.
Nadlewska A; Car H; Wiśniewska RJ; Wiśniewski K
Pol J Pharmacol; 2002; 54(2):95-102. PubMed ID: 12139116
[TBL] [Abstract][Full Text] [Related]
13. Effect of (S)-3,5-DHPG on learning, exploratory activity and anxiety in rats with experimental hypoxia.
Nadlewska A; Car H; Oksztel R; Wiśniewski K
Pol J Pharmacol; 2002; 54(1):11-8. PubMed ID: 12020039
[TBL] [Abstract][Full Text] [Related]
14. L-AP4, a potent agonist of group III metabotropic glutamate receptor, decreases central action of angiotensin II.
Fedosiewicz-Wasiluk M; Hoły ZZ; Wiśniewski K
Pol J Pharmacol; 2002; 54(5):415-22. PubMed ID: 12593528
[TBL] [Abstract][Full Text] [Related]
15. Selective blockade of the mGluR1 receptor reduces traumatic neuronal injury in vitro and improvesoOutcome after brain trauma.
Faden AI; O'Leary DM; Fan L; Bao W; Mullins PG; Movsesyan VA
Exp Neurol; 2001 Feb; 167(2):435-44. PubMed ID: 11161632
[TBL] [Abstract][Full Text] [Related]
16. Dopamine D4 receptor antagonist L745,870 abolishes cognitive effects of intracerebroventricular angiotensin IV and des-Phe(6)-Ang IV in rats.
Braszko JJ
Eur Neuropsychopharmacol; 2009 Feb; 19(2):85-91. PubMed ID: 18835699
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide].
Satow A; Maehara S; Ise S; Hikichi H; Fukushima M; Suzuki G; Kimura T; Tanak T; Ito S; Kawamoto H; Ohta H
J Pharmacol Exp Ther; 2008 Aug; 326(2):577-86. PubMed ID: 18487514
[TBL] [Abstract][Full Text] [Related]
18. Behavioral effects of dehydroepiandrosterone in adult male rats.
Fedotova J; Sapronov N
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):1023-7. PubMed ID: 15380863
[TBL] [Abstract][Full Text] [Related]
19. Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease.
Dekundy A; Pietraszek M; Schaefer D; Cenci MA; Danysz W
Brain Res Bull; 2006 Apr; 69(3):318-26. PubMed ID: 16564428
[TBL] [Abstract][Full Text] [Related]
20. NMDA receptor antagonists change behavioral activity of rats treated with (S)-4CPG.
Car H; Oksztel R; Nadlewska A; Wiśniewski K
Pol J Pharmacol; 2001; 53(4):331-9. PubMed ID: 11990079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
